-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on XPLR Infr, Lowers Price Target to $10

Benzinga·11/06/2025 15:14:41
Listen to the news
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $11 to $10.